Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

New p38 MAP kinase inhibitors emerge from Pfizer R&D

Sep. 21, 2004

New antitumor agents prepared and tested at Dr. Reddy's

Sep. 21, 2004

Novel L-DOPA prodrugs designed by Yissum researchers

Sep. 21, 2004

Wyeth claims new agents for VZV and other herpes virus infections

Sep. 20, 2004

Ivax patent covers new AMPA antagonists for stroke, epilepsy, etc.

Sep. 20, 2004

New COX-1 inhibitors under study at Fujisawa

Sep. 20, 2004

New antitumor agents prepared and tested at Servier

Sep. 20, 2004

Aventis describes cyclic urea-based inhibitors of IGF-1R and other kinases

Sep. 20, 2004

Three series of Src kinase inhibitors presented by AstraZeneca

Sep. 20, 2004

Glenmark scientists identify novel PDE4 inhibitors

Sep. 20, 2004

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...